Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects must be 18 years of age or older.
Ability to provide written informed consent.
Likely to complete all study visits.
Subjects must have one eye that with a diagnosis of infectious keratitis.
A corneal perforation.
Pregnancy or breastfeeding.
Active Herpes corneal disease.
Patient is unwilling or unable to comply with a medication regimen and follow up appointments.